Takushi Shirai Selected Research

pembrolizumab

12/2020

Hemophagocytic syndrome associated with pembrolizumab therapy successfully controlled by cyclosporin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takushi Shirai Research Topics

Disease

1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2021
1	Panniculitis 08/2021
1	Pain (Aches) 08/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2020
1	Neoplasms (Cancer) 11/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 11/2020
1	Infections 09/2020
1	Mycosis Fungoides 01/2017
1	Rhabdomyolysis 01/2016
1	Myasthenia Gravis 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016

Drug/Important Bio-Agent (IBA)

1	apalutamideIBA 01/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2021
1	Azathioprine (Imuran)FDA LinkGeneric 08/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2021
1	Prednisolone (Predate)FDA LinkGeneric 08/2021
1	pembrolizumabIBA 12/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	Trastuzumab (Herceptin)FDA Link 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	human ERBB2 proteinIBA 11/2020
1	Voriconazole (Vfend)FDA LinkGeneric 09/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2016
1	NivolumabIBA 01/2016
1	Cholinergic ReceptorsIBA 01/2016
1	AntibodiesIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2020
1	Combination Drug Therapy (Combination Chemotherapy) 11/2020